About this paper
Only a few months ago, the conversation about sharing clinical trial data was largely an argument of concerns and speculations against the idea. Spurred in part by growing momentum from government entities, the mood among life sciences companies has shifted to one of positive intention. It's just a matter of determining how to go about it. This article summarizes discussion on the topic with industry leaders at the second installment of the Clinical Trial Data Transparency Forum, sponsored by SAS, in February 2014.
SAS는 분석 부문의 선두 기업입니다. SAS의 혁신적인 소프트웨어와 서비스는 전세계 고객사가 데이터를 기반으로 인텔리전스를 극대화할 수 있도록 지원합니다. SAS는 THE POWER TO KNOW®를 실현합니다.